Detalhe da pesquisa
1.
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype.
Bioorg Med Chem Lett
; 51: 128376, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560263
2.
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties.
ACS Med Chem Lett
; 13(7): 1165-1171, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859878
3.
1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
Bioorg Med Chem Lett
; 18(18): 5027-31, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18752949
4.
Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.
Neuropsychopharmacology
; 41(2): 568-77, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105137
5.
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 13. Synthesis and profiling of a novel amminium prodrug of the HIV-1 attachment inhibitor BMS-585248.
J Med Chem
; 56(4): 1670-6, 2013 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23374053